Tadovas Tablet 20mg (Tadalafil)
Tadovas Tablet 20mg is a high-potency pharmacological intervention containing Tadalafil, a selective and reversible inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5). Specifically engineered for the clinical management of erectile dysfunction and the signs of benign prostatic hyperplasia (BPH), this formulation works by concurrently inhibiting the PDE5 enzyme and modulating the relaxation of vascular smooth muscles. By neutralizing the biochemical triggers that facilitate the degradation of cGMP in the corpus cavernosum, Tadovas effectively promotes an increased inflow of blood during sexual stimulation. This targeted biochemical action provides a decisive therapeutic response by reinforcing the structural uniformity of the erectile process and offering a prolonged duration of action—often referred to as the “weekend tablet” effect—compared to short-acting inhibitors.
Key Features
- Specifically formulated at a 20mg concentration to provide a therapeutic window of up to 36 hours.
- Clinically recognized for its role in facilitating the relaxation of vascular smooth muscles and maximizing arterial inflow.
- Effectively manages both erectile dysfunction and the lower urinary tract symptoms associated with prostatic enlargement.
- Acts as a functional catalyst to stabilize the physiological response to sexual stimuli over an extended period.
- Formulated to allow for greater spontaneity in intimate activity due to its long-lasting systemic presence.
Key Ingredients
- Tadalafil (20mg)
- Lactose Monohydrate
- Croscarmellose Sodium
- Hydroxypropyl Cellulose
- Magnesium Stearate
Precautions
- This is a high-potency vascular medication. Use must be strictly dictated by a healthcare professional after a full cardiovascular and urological assessment.
- Strictly prohibited for use with medications containing nitrates (e.g., nitroglycerin, isosorbide), as this can lead to a severe and potentially fatal drop in blood pressure.
- Use with extreme caution in patients with a history of myocardial infarction, stroke, or unstable angina within the last 6 months.
- Seek immediate medical intervention if an erection persists for longer than 4 hours, as this can cause permanent tissue damage.
- Discontinue use immediately if sudden loss of vision or hearing occurs and consult a specialist.
- Keep the container tightly closed and store in a cool, dry place (below 25°C). Protect from direct light and moisture to maintain the molecular stability of the active ingredient.
How to Use
- The tablet should be swallowed whole with a glass of water. It may be administered with or without food.
- The standard dose for “as-needed” use is 20mg, but the exact regimen must be specifically dictated by your healthcare professional. Do not exceed one dose in a 24-hour period.
- For optimal clinical results, administration should occur at least 30 to 60 minutes prior to anticipated activity. Its effects may persist for up to 36 hours.
- Note that sexual stimulation is a clinical requirement for the medication to initiate its physiological effects.
- Unlike other PDE5 inhibitors, the absorption of Tadalafil is not significantly affected by high-fat meals. Avoid excessive alcohol consumption.
- Use only as required. Maintain regular follow-ups with your physician to monitor the efficacy and systemic safety of the treatment.
Legal Disclaimer: Tadovas Tablet 20mg is a specialized pharmacological intervention for erectile dysfunction. Individual results vary based on the patient’s baseline cardiovascular health and underlying causes of dysfunction. This product is for use under professional medical guidance only. This information is for educational purposes and is not a substitute for professional medical consultation or a formal clinical diagnosis.









Reviews
There are no reviews yet.